Defense Advanced Research Projects AgencyTagged Content List

Medical Devices

Relating to non-pharmacologic interventions to diagnose, prevent or treat disease or injury

Showing 10 results for Med-Devices + Syn-Bio RSS
DARPA’s Biological Technologies Office develops capabilities that embrace the unique properties of biology—adaptation, replication, complexity—and applies those features to revolutionize how the United States defends the homeland and prepares and protects its Soldiers, Sailors, Airmen, and Marines. BTO is helping the Department of Defense expand technology-driven capabilities to detect novel threats and protect U.S. force readiness, deploy physiological interventions to maintain operational advantage, support warfighter performance, and focus on operational biotechnology for mission success.
DARPA published its Young Faculty Award (YFA) 2018 Research Announcement today, seeking proposals in 26 different topic areas—the largest number of YFA research areas ever solicited.
DARPA has enjoyed a strong relationship with Silicon Valley since the early 1960s, working with innovators to lay the groundwork for new industries built around Agency investments in semiconductors, networking, artificial intelligence, user interfaces, programming, materials, microsystems, and more. Biotech is now emerging as a breakthrough opportunity space and it represents an area that is ripe for fresh collaboration among DARPA, the nation’s top researchers, venture capitalists, and entrepreneurs.
December 4, 2019, 8:00 AM EST,
Webinar OR George Mason University Auditorium
The Biological Technologies Office is holding a Proposers Day meeting and webinar covering the new Personalized Protective Biosystem (PPB) program. PPB aims to develop technology that reduces the need for burdensome protective equipment while increasing individual protection against chemical and biological threats. The program comprises two technical areas: 1) reactive materials that prevent threat agent access to the body; 2) a configurable barrier countermeasure that neutralizes threat agents at vulnerable points of entry (i.e., skin, airway, ocular).
The DoD requires timely and comprehensive threat detection to support overall readiness, counter the spread of disease, and promote stabilization missions. State of the art diagnostic and biosurveillance systems are unable to keep pace with disease outbreaks and fail to support decision-making at the time and place of need. The “Detect It with Gene Editing Technologies” (DIGET) program aims to leverage advances in gene editing technologies to develop field-forward diagnostic and biosurveillance technologies that enable detection of any threat, anytime, anywhere.